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ABSTRACT 
 
Efficient replication and assembly of virus particles are integral to the 
establishment of infection. In addition to the primary role of the capsid protein 
(CP) in encapsidating the RNA progeny, experimental evidence on positive sense 
single-stranded RNA viruses suggest that CP also regulates RNA synthesis. Here, 
we demonstrate that replication of Satellite tobacco mosaic virus (STMV) is 
controlled by the cooperative interaction between STMV capsid protein (CP) and 
the helper virus (HV) Tobacco mosaic virus (TMV) replicase. We identified that the 
STMV CP-HV replicase interaction requires a positively charged residue at the 
third position (3R) in the N-terminal 13aa motif. Far-Northwestern blotting showed 
that STMV CP promotes binding between HV-replicase and STMV RNA. An STMV 
CP variant having an arginine to alanine substitution at position 3 in the N-
terminal 13aa motif abolished replicase-CP binding. The N-terminal 13aa motif of 
the CP bearing alanine substitutions for positively charged residues located at 
positions 5, 7, 10 and 11 are defective in packaging full-length STMV, but can 
package a truncated STMV RNA lacking the 3’ terminal 150 nt region. These 
findings provide insights into the mechanism underlying the regulation of STMV 
replication and packaging. 
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Introduction 
Satellite tobacco mosaic virus (STMV) was originally found in association with 
helper virus (HV) Tobacco mosaic virus (TMV strain U5) in natural infections of tree 
tobacco (Nicotiana glauca) 1. The replication of STMV depends on the RNA-dependent 
RNA polymerase (RdRp) encoded by TMV U5, which has since been renamed Tobacco 
mild green mosaic virus. Other strains of TMV such as U1 and U2 also have been 
shown to support the replication of STMV 1. The genome of STMV is composed of a 
single-stranded, positive-sense RNA of 1059 nucleotides (nt) 2,3. STMV RNA does not 
show appreciable sequence homology with helper TMV RNA, except for the 3’-
terminal150 nt that exhibit 65% homology with the corresponding tRNA-like structure 
(TLS) located at the 3’ end of TMV RNA 2. Biologically active icosahedral virions of 
STMV are 17-18 nm in diameter with a T=1 symmetry 4 and are assembled from 60 
identical capsid protein (CP) subunits of 17.5 kDa 2. The 3D structure of STMV has 
been determined at 1.8 Å 5.  
A hallmark feature of STMV is that it is the only satellite virus, whose HV is a rod-
shaped tobamovirus. Additionally, STMV stands out among other spherical viruses 
because of the high degree of order adopted by the RNA within the capsid6. Despite its 
simple genome organization, information concerning STMV replication is limited7,8. 
Previous studies7 revealed that a mutation engineered to completely block CP synthesis 
severely reduced the replication of STMV while a variant designed to express only the 
N-terminal13 amino acid (aa) motif retained wild type replication via an unknown 
mechanism.  
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Using an Agrobacterium-based transient expression system (agroinfiltration) we 
recently reported several interesting properties of STMV when expressed in the 
presence and absence of its HV RdRp 9. In the current study, we extended the 
agroinfiltration system to further shed light on the contribution of the CP, more 
specifically the N-terminal 13aa motif to STMV replication. We have engineered a series 
of mutations affecting the positively charged amino acids located within the N-terminal 
13aa motif and evaluated their effect on replication and packaging. Application of a wide 
range of molecular techniques revealed that replication and packaging are regulated by 
protein-protein (i.e. CP and HV-RdRp) and protein-RNA-protein (i.e. HV-RdRp-STMV 
RNA-CP) interactions. First, we found that, the N-terminal 13aa motif has a regulatory 
role in STMV replication. Second, the genomic context of the N-13aa motif has a 
profound influence in modulating (+) and (-)-strand accumulation. Third, a single 
positively charged arginine residue located at the third position in the N-terminal 13aa 
motif of the CP is obligatory for the interaction between CP and HV-RdRp. Fourth, a 
Far-Northwestern analysis revealed that CP is obligatory to promote interaction 
between HV-RdRp and STMV RNA  (i.e. protein- protein-RNA interaction). Finally, we 
observed that STMV CP bearing alanine substitutions for positively charged residues 
located at positions 5, 7, 10 and 11 specifically are defective in packaging full-length 
STMV genomic RNA. This study shows that packaging and replication of STMV RNA 
are regulated by the N-terminal 13aa motif of the CP. 
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Results 
 
Evidence showing that the N-terminal 13aa motif of STMV CP is 
obligatory for replication. The genome organization of STMV RNA and the 
sequence of the first 25 N-terminal aa of the CP gene are shown in Fig. 1A. Among 
these 25 aa, the first 13aa are rich in basic residues and are predicted to interact with 
RNA inside the assembled capsid 10.  Application of DisProt 11 predicted that the N-
terminal 25 aa region is disordered while the remaining 134 aa are highly ordered (Fig. 
1B). Preliminary data on the replication of STMV in plant protoplasts suggested a role 
for STMV CP and more specifically for the N-terminal13aa in replication 7. We opted to 
extend the Agrobacterium-mediated transient expression system (agroinfiltration) 
developed recently for STMV in our lab 9 in dissecting the mechanism involving the CP-
regulated STMV replication. To this end, we constructed three independent variant 
agrotransformants of wt STMV (pSTMV; Fig. 1C). These are as follows: (i) 
Agrotransformant CPKO was constructed by substituting the translation initiating 
methionine codon located at nucleotide 162-164 with a stop codon (i.e. 
162AUG164è162UAG164) (Fig. 1C); (ii) agrotransformant CPD13aa was designed to 
express the CP devoid of the first 13aa by engineering a stop codon at the translation 
initiation site and a start codon ataa14 (Fig. 1C) and (iii) agrotransformant CP13aa was 
designed to express only the first 13aa by engineering a stop codon at aa position 14 
(Fig. 1C). 
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Each of the above-mentioned three agrotransformants was mixed with 
agrocultures of pRP to provide the HV RdRp (Fig. 1C) and co-infiltrated into N. 
benthamiana leaves. Plants co-infiltrated with pSTMV and pRP served as positive 
controls. At five days post infiltration (dpi), total RNA and protein preparations were 
isolated and subjected respectively to duplicate Northern blot hybridization to detect 
progeny (+) and (-)-RNA and Western blot analysis. Duplicate Northern blots probed for 
assessing the affect of CP on the accumulation of progeny (+) and (-)-strands are 
shown in Fig. 2A. Quantitative analysis of progeny RNA with respect to the wt control is 
tabulated and shown in Fig. 2B. This experiment was repeated three times and we 
consistently observed that the presence of CP, more specifically the N-terminal13aa, 
had profound influence on progeny accumulation. Quantitative data in Fig. 2B 
represents the relative (+) and (-)-strand accumulation for each CP mutant when 
compared internally to that of wt. It was observed that, complete absence of CP, 
exemplified by the behavior of CPKO, decreased the plus-strand accumulation by 90% 
while minus-strand accumulation was not affected. By contrast, CP lacking the N-
terminal 13aa motif (i.e. CPD13aa) reduced the plus-strand accumulation by 47% while 
a 3-fold increase in minus-strand accumulation was observed. Interestingly, expression 
of only the N-terminal 13aa motif had no detectable effect on plus-strand accumulation 
while a 4-fold increase in minus-strand accumulation was observed (Fig. 2B). Taken 
together, these results suggested that the N-terminal13aa region of the STMV CP has 
two independent roles for regulating (-) and/or (+)-strand synthesis (see Discussion). 
With respect to CP accumulation, as expected, in addition to the wt control, a detectable 
level of a faster migrating CP was accumulated for variant D13aa but not for other 
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variants (Fig. 2A). To detect the CP of 13aa by Western blot, the 13aa was FLAG 
tagged and its expression was confirmed by using anti-FLAG monoclonal antibodies 
(Fig 6A). 
Recently, we demonstrated that production of a truncated form of STMV RNA is 
a hallmark feature associated with STMV replication in N. benthamiana 9. It was 
observed that with either mechanical inoculation of STMV with its HV or co-expression 
of STMV with HV-RdRp via agroinfiltration, a truncated non-replicative form of STMV 
lacking the 3’ terminal 150 nt (i.e. STMVD150) was also accumulated along with the wt 
genomic RNA. Additional experiments demonstrated that production of STMVD150 is 
linked to HV-dependent replication and is not a product of ribonuclease activity 9.To 
verify the production of STMVD150 in leaves expressing each of the three variant 
agrotransformants (CPKO, ∆13aa and 13aa), total RNA preparations were subjected to 
RT-PCR. Production of STMVD150 was associated with either wt STMV (Fig. 2A, lane 1 
in RT-PCR panel) or a variant competent to express the 13aa (i.e. CP 13aa in Fig. 2A, 
lane 5 in RT-PCR panel) but not with those variants defective in expressing 13aa i.e. 
CPKO or CPD13aa (Fig. 2A, lanes 3 and 4 in RT-PCR panel). Since the production of 
STMVD150 is linked to HV-dependent replication 9 and the fact that expression of the 
13aa plays a crucial role in STMV replication (Figs. 2A and 3B) 7., these observations 
suggest that expression of the 13aa is linked to the production of STMVD150 by an 
unknown mechanism. 
To test the effect of the N-terminal13aa deletion on virion assembly, 
agrotransformants of CPKO, CPD13aa and 13aa were co-expressed with 
agrotransformant pRP in N. benthamiana leaves. Plants co-infiltrated with pSTMV and 
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pRP served as positive controls while those infiltrated only with empty vector served as 
negative controls.  At 4 dpi, virions were purified, negatively stained and examined by 
Transmission Electron Microscopy (TEM). Icosahedral virions of 18 nm characteristic of 
STMV were recovered from leaves infiltrated with pSTMV and pRP (Fig. 2C). By 
contrast, no virions were detected in leaves infiltrated with any of the three CP variants 
(Fig. 2C). In agreement with previous findings 5, our observations further confirm that 
the N-terminal13aa region is required for virion assembly. 
 
A positively charged amino acid at position 3 is obligatory for efficient 
replication of STMV. Results shown in Fig. 2A accentuate the importance of the N-
terminal13aa region in STMV replication. To precisely identify the role of positively 
charged aa encompassing the N-terminal13aa of STMV CP on replication, an alanine 
residue was substituted for a desired arginine or lysine residues normally located within 
the 13aa N-terminal region resulting in the construction of a set of five variants of CP 
13aa (i.e. 13aa/3A, 13aa/5A, 13aa/7A, 13aa/10A and 13aa/11A in Fig. 3A). Each of 
these CP agrotranformants was co-infiltrated with pRP into N. benthamiana leaves and 
progeny were evaluated using Northern blot and RT-PCR analyses (Fig. 3). Northern 
blots were probed for assessing the affect of CP and its variants on the progeny 
accumulation (Fig. 3B) and quantitated as described above (Figs. 3C).   
First, we evaluated the affect of the N-terminal 13aa motif and five variants on 
plus-strand accumulation (Fig. 3B, panel i). Except for variant 13aa/3A, plus-strand 
accumulation for the remaining four variants was indistinguishable from that of the 
internal control (i.e. wt) (Fig. 3C). Secondly, we evaluated the effect of these mutants on 
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minus-strand accumulation (Fig. 3B, panel ii). Since each of the five alanine 
substitutions were engineered into the genetic background of the wt 13aa construct, 
data was normalized against wt 13aa. Except for variant 13aa/3A, where the (-)-strand 
accumulation was equivalent to that of the control (i.e. 13aa), a 3-fold increase in minus-
strand accumulation was observed for the remaining four variants (Fig. 3C). Taken 
together, these observations accentuate the significance of that having a positively 
charged residue at their respective positions, specifically at 3rd position is obligatory for 
sustained replication.  
Results of RT-PCR analysis evaluating the production of STMV D150 are shown 
in Fig. 3B. Production of STMV D150 was found associated with all variants except for 
13aa/3A (Fig. 3B). Collectively, data encompassing replication profiles (Fig. 3B), 
quantitative analysis of strand asymmetry (Fig. 3C) and RT-PCR (Fig. 3B) analysis 
suggested that the arginine and the lysine residues at the N-terminus plays a significant 
role for maintaining wild type replication of the STMV RNA. More specifically a positively 
charged residue at the 3rd position is intimately involved with the replication of STMV 
(also see below).  
 
Replication of full-length STMV CP variants harboring N-terminal 
mutations. Next we wanted to evaluate the replication and packaging phenotypes of 
full-length STMV CP bearing each of the six N-terminal alanine substitution variants(Fig. 
3A). Consequently, each of the five-alanine substitution variants (Fig. 3A) was 
engineered into the CP ORF of the full-length STMV agrotransformant (Fig. 4A) and its 
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effect on replication, translation, virion assembly and genome packaging was evaluated. 
Results are shown in Figs. 4 and 5. 
Northern blot hybridization results on the effect of the five-alanine mutations on 
STMV replication are shown in Fig. 4B and the quantitative data on the relative 
accumulation levels of (+) and (-)-strand progeny is shown in Fig. 4C.  Consistent with 
the data shown in Fig. 3B, despite near wt levels of (-)-strand accumulation, a >90% 
reduction in the accumulation of (+)-strand was observed for variant 3A (Fig. 4B, lane 1; 
Fig. 4C).  For the remaining four variants (ie. 5A, 7A, 10A and 11A), a 30 to 50-fold 
stimulation (in relation to wt) in the accumulation of (+)-strand was observed (Fig. 4B, 
lanes 2-5) which was contrary to the accumulation level seen with the same variants 
engineered in the CP 13aa construct (Fig 3). Results of RT-PCR assays used to 
evaluate the production of STMV D150 are similar to those shown in Fig. 3B, i.e. STMV 
D150 was present in total RNA preparations of all variants except 3A (Fig. 4B, bottom 
panel). 
Results shown in Figs. 3 and 4 clearly indicate that at position 3, a positively 
charged amino acid residue is preferred. To substantiate this, the arginine residue at 
position 3 was substituted with another basic amino acid namely, a lysine residue (i.e. 
3R to 3K, Fig. 4A) and its effect was examined on replication, CP synthesis and 
production of STMV D150. Results summarized in Fig. 4 (D and E) confirm the 
importance of a positively charged residue at position 3.     
 
Effect of N-terminal mutations on STMV assembly and packaging. 
Western blot analysis revealed that all four other variants (5A, 7A, 10A and 11A) were 
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competent to translate higher levels of CP than wt. Among four variants, CP production 
was more prominent with variant 7A than others (Fig. 4E). By contrast, CP for variant 
3A was only detectable when a 10-fold excess of total protein was loaded (Fig. 4F). To 
verify whether these variants were competent to assemble into virions or virion like 
particles (VLPs), virions were purified from infiltrated N. benthamiana leaves. Fig. 5 
summarizes the results. EM and Northern blot hybridization evaluated the physical 
morphology of purified virions and their packaging phenotypes, respectively. The 
biological nature of the purified virions was tested by an infectivity assay. Results are 
summarized in Fig. 5. Icosahedral virions of 18 nm were detected in wt as well as in 
variants 5A, 7A, 10A and 11A but not in variant 3A (Fig. 5A). Northern blot analysis of 
viron RNA profiles revealed interesting results. For example, only virions of wt contained 
full-length STMV RNA as well as truncated STMV (i.e. STMV D150) (Fig.5B, lane 6), a 
characteristic feature of STMV in N. benthamiana 9. By contrast, virions of all four 
variants contained only the truncated STMV D150 but not full length (Fig. 5B, lanes 2-5). 
Presence of full length and STMV D150 in virion preparations of wt and the absence of 
full length and presence of STMV D150 in all four CP variants were further confirmed by 
an RT-PCR assay (Fig.  5C). In contrast to the wt control (Fig. 5D, lane 1), the inability 
to induce infection in N. benthamiana plants mechanically inoculated with virions of HV 
and each of the four CP variants (Fig. 5D, lanes 2-6) further confirm that CP variants 
are incompetent to package full length STMV RNA. Reasons for this defective 
packaging phenotype are considered under the Discussion. 
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Evidence for a physical interaction between HV-RdRp and STMV CP. 
Although replication of STMV depends on HV RdRp, results shown in Figs. 2-5 
demonstrate that STMV CP, more specifically its N-terminal 13aa motif, has a 
regulatory role in the replication. Therefore to test whether STMV CP physically 
interacts with HV RdRp, we performed the following experiment. One set of N. 
benthamiana plants was infiltrated to co-express HV RdRp (i.e. pRP, Fig. 1C) and either 
wt STMV or one of three selected N-terminal CP variants (3A, 5A and 7A). Another set 
of N. benthamiana plants was infiltrated to co-express pRP and only 13aa tagged with 
FLAG (13aac-FLAG). Plants co-infiltrated with P19 and either pSTMV or 13aac-FLAGserved 
as controls. At 4 dpi, total proteins were extracted from infiltrated leaves and incubated 
with anti-126 kDa antibodies, followed by the precipitation of the complex with protein 
G-agarose beads and Western blotting with anti-126 kDa, CP or Anti-FLAG antibodies. 
Results are shown in Fig. 6A. It was observed that wt CP, variants 5A and 7A, but not 
3A, were co-precipitated with HV RdRp (i.e. Anti-126 kDa) (Fig. 6A, panel ii). These 
results validate that a direct or indirect interaction exists between HV-RdRp and STMV 
CP and the arginine residue located at position 3 is obligatory in promoting this 
interaction. In addition, RNase A treatment did not disrupt the co-precipitation of anti-
126 kDa and CP (Fig.6B), suggesting that RNA is not involved in promoting the 
interaction between HV RdRp and CP. 
 
Evidence showing interaction of STMV RNA with HV RdRp requires 
CP. Northern blot results (Figs. 2-4) demonstrate the importance of CP in STMV 
replication while results of Co-IP assays (Fig. 6A) demonstrate that CP physically 
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interacts with HV RdRp. Does interaction of HV RdRp with STMV RNA require CP? To 
answer this question, we performed a Far-Northwestern assay. Results are shown in 
Fig. 7 (A, B). Since variant 3A translates inefficiently in vivo (Fig. 4F), a Northwestern 
analysis was performed using in vitro translation products of wt and four CP variants 
(CPKO, 3A, 5A and 7A) and32P-labeled STMV RNA as a binding probe. Interaction 
between STMV RNA and CPs of wt, variants 5A and 7A, but not with either CPKO or 
variant 3A, was detectable [Fig. 7A, panel (ii)]. These Northwestern analyses confirm 
interaction between CP and RNA while Co-IP assays (Fig. 6A) established that CP 
physically interacts with HV RdRp. To further evaluate whether CP is required to 
promote interaction between STMV RNA and HV RdRp, we performed another Far-
Northwestern analysis. Results demonstrated that the presence of STMV CP enabled 
the interaction between HV RdRp and STMV RNA [Fig. 7B, panels (I to iii)]. Taken 
together these results provide evidence that CP enhances selection of STMV RNA 
templates by HV RdRp. 
 
Discussion 
 
Viral replication is a complex process involving numerous macromolecular interactions 
12. In positive strand RNA viruses, although replication is primarily catalyzed by virus 
encoded RNA-dependent-RNA polymerase (RdRp), several lines of evidence suggest 
that CP is intimately associated with this active process to stimulate replication 12. For 
example, CP-regulated viral RNA synthesis occurs via CP-RNA interactions as in the 
case of Alfalfa mosaic virus (AMV) 13,14 or CP-RdRp interactions as in the case of 
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member viruses of the Coronaviridae 15 and rubella virus 16 or CP functioning as a RNA 
chaperone 11,17,18. The results presented here demonstrate that a cooperative 
interaction between HV- RdRp and STMV CP (Fig. 2A), more specifically the N-
terminal13aa region (Figs. 3 and 4), plays an important role in STMV replication and 
packaging. Mutational analysis further revealed that a positively charged residue at the 
third position in the N-terminal 13aa motif (Figs. 3B, 4B, 4D and 6A) promotes the 
physical interaction between HV-RdRp and STMV CP. These features are commonly 
shared with AMV 14,19 and rubella virus 16. In AMV, minus-strand synthesis requires the 
viral RNA to be in a 3’ pseudoknot conformation and to be free of CP; upon CP binding 
a conformational switch blocks minus-strand synthesis and favors plus-strand synthesis 
20,21. However, since the 3’ UTR of STMV inherently mimics a TLS, a conformational 
switch analogous to AMV is not required to initiate minus-strand synthesis. Similar 
levels of minus-strand accumulation between wt and the CP defective variant CPKO 
(Fig. 2A, compare lanes1 and 3) suggest that in STMV minus-strand synthesis by HV 
RdRp is independent of the CP. 
Our results exemplify that STMV CP (Fig. 2), specifically the basic N-terminal 
13aa motif (Figs. 3A and 4A) actively participates in modulating (+) an/or (-)-strand 
synthesis. As discussed below, this active participation in STMV RNA replication 
depends on the genomic context of the N-terminal 13aa motif. First, the critical role 
played by the CP is exemplified when the replication profile of wt and mutant CPKO is 
compared (Fig. 2A). Since the levels of (-)-strand accumulation for wt and mutant CPKO 
are indistinguishable (Fig. 2A, compare lanes 1 and 3). It is reasonable to conclude that 
CP has no detectable effect on (-)-strand synthesis and a significant reduction in (+)-
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strand synthesis by mutant CPKO (Fig. 2A, lane 3) suggests CP plays a critical role in 
(+)-strand synthesis.  
Co-expression of wt 13aa (Fig 2) along with HV RdRp stimulated both (+) and (-) 
strands accumulation equally (Fig 2A lane 5) whereas co-expression of ∆13aa 
significantly reduced (+)-strand accumulation compared to that of (-)-strand (Fig 2A 
compare lane 4 and 5). This suggests that the role of N-terminal 13aa motif is attributed 
to (+) strand synthesis. However, on mutating four of the five positively charged amino 
acids to alanine in the wt 13aa (i.e. 5A, 7A, 10A and 11A), the balanced accumulation of 
(+) and (-)-strand RNA was altered resulting in increased accumulation of (-)-strands 
(Fig. 3B). Interestingly, this scenario was changed when the above-mentioned four 
mutants were incorporated into the background of full length CP. This is exemplified by 
increased accumulation of (+)-strands over the (-)-strands (Fig. 4B).  Collectively, these 
observations suggest that (+) and (-)-strand accumulation is regulated by the context of 
the N-terminal 13aa motif based.  
Another interesting outcome of our study is the intrinsic role played by a 
positively charged residue at position 3 of the N-terminal 13aa motif. For example, 
substitution of an alanine residue for arginine at position 3 (i.e. 3Rè3A; Figs. 3A and 
4A) had very little effect on (-)-strand synthesis (Fig. 3B, line 4; Fig. 4B, line 1) while 
plus-strand synthesis was down regulated by nearly 80% (Figs. 3B, C and 4B, C). An 
analogous scenario was observed in AMV. Mutational analysis of the N-terminal basic 
residue of AMV CP revealed that substitution of alanine for lysine at position 18 
completely abolished replication 19. As discussed below, this down-regulation of 
progeny accumulation is due the absence of physical interaction of CP with HV-RdRp.  
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Results from co-immunoprecipitation analysis revealed that STMV CP interacts 
with HV RdRp (Fig 6A lane 4). Although this phenomena was previously observed in 
other RNA viruses such as brome mosaic virus and flock House Virus (15) but not for 
satellite viruses. Results of this study represents first example demonstrating that STMV 
RNA replication requires a physical interaction between CP and its HV-RdRp. 
Furthermore, North-Western and Far North Western analysis (Fig. 7, A and B) 
accentuated that the presence of a positively charged residue at the 3rd position is 
obligatory to promote CP-HV RdRp interaction.  
We recently demonstrated that replication of STMV in N. benthamiana, but not in 
N. tabacum, generate a truncated RNA (i.e. ∆150 characterized by lacking the 3’ 
terminal 150 nt) along with the full length RNA (9). Results of this study revealed that 
production of ∆150 is linked to HV-dependent replication since it was not detected in 
plants infiltrated with replication defective variants of STMV (i.e. CPKP and 3A; Figs. 3 
and 4). 
In general, it is widely accepted that electrostatic interactions are the driving force 
for virion assembly in that the positively charged domains on viral CPs neutralize most 
of the negative charges of the RNA22-29. Many in vitro viral self-assembly studies show 
that RNA packaging can be largely explained through electrostatic interactions 24. 
Based on these experimental observations, we recently introduced a very simple 
generic model to study the spontaneous encapsulation of genome by the CP30.  In this 
model, we consider RNA as a negatively charged polymer interacting attractively with 
positively charged CP. More specifically, we use a phenomenological model to 
investigate the total free energy of the virion, Fvirion=Fcapsid+FRNA+Fint, with Fcapsid the free 
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energy of the capsid, Fint the free energy associated with capsid-RNA interactions and 
FRNA the free energy of RNA. Since STMV CP is positively charged, we model the 
capsid as a charged sphere so the term Fcapsid involves the repulsive electrostatic 
interaction between positive charges on the CP. In our approach, RNA is modeled as a 
self-avoiding flexible branched chain. Thus the term FRNA includes the contribution of 
RNA entropy, the secondary structure of RNA, and the excluded volume interaction 
related to the second viral coefficient. We find the optimal length of RNA and its 
distribution within the capsid through minimization of the free energy Fvirion explained 
above. 
Data shown in Fig. 8 demonstrates the result of our calculations, Fvirion vs genome 
length.  The σ in the figure corresponds to the charge density of the inner wall of the 
capsid. It is 0.24 electron/nm2 for the capsid constructed by mutated coat proteins (5A, 
7A, 10A and 11A) and it is 0.3 electron/nm2 for the wt capsid. The solid black curve 
shows the free energy of RNA encapsulated by wt proteins while the dashed red curves 
correspond to that by the mutated coat proteins. Blue dots and orange squares 
respectively represent the encapsidation free energy of STMV∆150 (908 nt) and wt 
RNA (1058 nt).  As illustrated in the figure, in the case of mutated capsid, the 
encapsidation free energy of STMV∆150 RNA is significantly lower than that of wt RNA 
(14.28kBT) leading to the exclusive encapsulation of STMV∆150 RNA. However, in the 
case of wt CP, the encapsulation free energy of STMV∆150 RNA is lower than that of wt 
RNA by only 1.47kBT, explaining why both STMV∆150 and wt RNA can be 
encapsidated by wt CP. As a matter of fact, while the ratio of free STMV∆150 to wt RNA 
is very low (24:76) 9, the ratio of packaged STMV∆150 to wt RNA is much larger (55:45) 
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indicating a clear preference for encapsidation of the shorter RNA. More specifically, 
these calculations reveal that the electrostatic interaction between mutated capsid 
proteins and full length RNA is not strong enough to compactify the genome to fit in a 
small size capsid. In other words, due to the size of STMV capsid, the energetic cost of 
encapsidation of negatively charged wt RNA is very high and thus the shorter genome 
is encapsidated more favorably even by wt capsid proteins. While the number of 
charges on the wt capsid proteins is sufficient to encapsidate the full length genome, it 
is important to note that wt RNA gets encapsidated much less efficiently than ∆150. 
These theoretical results offer the basis to explain results presented in Fig. 5C.   
As noted above, electrostatics clearly explains the results corresponding to 
variants 5A, 7A, 10A and 11A presented in Fig. 5C. However, a question that naturally 
arises would be why does the CP bearing the 3A mutation not encapsulate either 
STMVD150 or wt RNA? We offer the following explanation. Our observations (Fig. 5C) 
suggest that non-specific interactions are insufficient to drive the self-assembly of a 
ssRNA virus by CP. The presence of an arginine residue located at position 3 reveals 
the necessity of a specific interaction between RNA and CP for the successful assembly 
of a virion.  The interaction could be due to a specific nucleation site on the CP for RNA 
or the specific CP-RNA interaction could alter the conformation of the CP resulting in a 
stronger protein-protein interaction leading to virion assembly. The experiments 
presented in this paper show that an amino acid residue (i.e. arginine) at a specific site 
(i.e. position 3) is crucial for successful packaging. Identification and disruption of 
contacts between particular CP residues and RNA could contribute to our knowledge of 
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developing novel antiviral drug strategy for RNA pathogenic to pathogenic to humans 
and animals. 
 
Methods 
 
Agro-constructs and Agro-infiltration. The construction and characteristic features of 
an agro-construct of STMV (pSTMV; Fig. 1A) have recently been described 9. All CP 
variants constructed in this study are incorporated into the genetic background of 
pSTMV using a mega PCR approach 31. Briefly, to construct the N-terminal CP variants 
(Fig. 1C) 3RèA, 5KèA, 7KèA, 10RèA, 11KèA and 5R+7Kè5A+7A (refer to as 
57A; Fig. 1C), STMV CPKO, STMV 13aa, STMV 13aa/A and STMV 13aa/B(Fig 5A), the 
CP gene harboring nucleotides (nt) 159 to 614 was first amplified with the following 
forward primers (For 3RèA 5’GCTATGGGGGCAGGTAAGGTTAAACC3’, 5’ 
GCTATGGGGAGAGGTGCAGTTAAACC3’,for 5KèA 5’ 
GGGGAGAGGTAAGGTTGCACCAAACC 3’; for7KèA 5’ 
GGTAAGGTTAAACCAAACGCAAAATCGACG 3’; FOR 10RèA 5’ GGTTAAACCAAAC 
CGTGCATCGACG 3’; 5’  for CPKO, 
5’CTGTTTCCAGCTTAGGGGAGAGGTTAGGTTAAACC3’;for 13aa, 
5’CGTAAATCGACGTAGGACAATTCGAATG 3’; for 13aa/A5’ 
GCTATGGGGGCAGGTAAGGTTAAACC 3’; 13aa/B 5’ 
CCAGCTATGGGGAGAGCAGCAGCAGCAGCAGCAGCAGCATCGACGTAGGACAAT
TCG 3’) and a commonly shared reverse primer (5’ GGCGACTTGTCGACAGTTGC 3’; 
SalI site is underlined). The resulting PCR products were gel purified and used as mega 
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primers in a PCR reaction. A region spanning the sequence of pSTMV from nt768-614 
was amplified using a forward primer (5’CGCCAAGCTTGCATGCCTGCAGG3’; HindIII 
site is underlined) and each mega primer for the respective variant prepared above. The 
resulting PCR products were digested with HindIII and SalI and sub-cloned into a 
similarly treated pSTMV.  The nature of all recombinant clones was verified by DNA 
sequencing. Transformation of wild type and variant pSTMV agroconstructs to 
Agrobacterium strain GV3101 followed by infiltration into the abaxial side of the fully 
expanded N. benthamiana leaves was as described previously 32. 
Mechanical inoculation, progeny analysis, packaging assays and EM 
analysis. Procedures used for mechanical inoculation of N. bethamiana with STMV 
variant virions in the presence of TMV U5, isolation of total RNA from agroinfiltrated 
leaves, purification of STMV virions, Northern blot analyses are as described 
previously9,33,34 For electron microscopy analysis, purified wild type and variant STMV 
virions were further subjected to 10%-40% sucrose gradient centrifugation and spread 
on glow-discharged grids followed by negative staining with 1% uranyl acetate prior to 
examination with JEM 1200-EX transmission electron microscope operated at 80 keV, 
and images were recorded digitally with a wide-angle (top mount) BioScan 600-W 1︎1K 
pixel digital camera 33. 
 
RT-PCR. Virion RNA from wild type and CP variants were subjected to Poly–A tailing 
using E. coli poly A polymerase according to the manufacturer’s protocol (NEB). 
Following inactivation of poly A polymerase by heat (95ºC for 2 to 3 minutes), first 
strand cDNA was synthesized using a reverse primer (5’ 
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GGGAGGACACAGCCAACATACGTATTTTTTTTTTTTTTTTTTTTT 3’; SnaB I site is 
underlined) and M-MulV reverse transcriptase (New England Biolabs). The resulting 
product was subjected to PCR using a forward primer (5’ 
TACGTAAACTTACCAATCAAAAG 3’) and a reverse primer 
(5’GGGAGGACACAGCCAACATACGTA3’; SnaB I site is underlined). PCR products 
were finally analyzed by agarose gel (1%) electrophoresis then visualized and 
photographed under UV light following ethidium bromide staining. 
 
Co-immunoprecipitation assay (Co-IP). Total protein extracts were prepared 
from healthy and agroinfiltrated N. benthamiana leaves as described previously 35. 
Isolated proteins were incubated with anti-126 kDa protein antibody at 1:100 dilution 
(kindly provided by Rick Nelson) for 8 h at 4°C. Then, a 30-µl aliquot of protein G-
agarose beads (Santa Cruz Biotechnology, USA) was added to each tube, followed by 
incubation for 2 h at room temperature. The immune complexes were then precipitated 
by centrifugation for 1 min at 10,000 x g and washed three times in 1 ml of phosphate-
buffered saline (0.1 M NaCl, 90 mM sodium phosphate [pH 7.0]). For RNase A 
treatment, the precipitated proteins were treated with RNase A (50 µg/ ml) for 2 h at 
25°C31. The resulting precipitated proteins were eluted from the beads by boiling in 
SDS-PAGE sample buffer for 3 min. Equal volumes of protein samples were analyzed 
by SDS-PAGE, followed by immuno blot analysis with anti-126-kDa and anti-STMV CP 
antibodies. 
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In-vitro translation of CP. N. benthamiana leaves were co-infiltrated with 
agrotransformants of STMV wt or CP variants 3A or 5A or 7A and TBSV P19, a 
suppressor of RNA silencing 36. Total RNA isolated from each of these infiltrated leaves 
was used to produce their respective CPs using a wheat germ in vitro translation kit 
(Promega Corporation) and subjected to Western, Northwestern and Far-Northwestern 
blot analyses. 
  
Western, Northwestern and Far-Northwestern analyses. Western blot 
analysis was performed as described previously 9. For Northwestern analysis 14, wild 
type or desired variant CPs of STMV were resolved by 10% or 12% SDS-PAGE and 
transferred to a nitrocellulose membrane. Proteins immobilized on the nitrocellulose 
membrane were re-natured overnight in a buffer containing 15 mM HEPES (pH 8.0), 10 
mM KCl, 10% glycerol, and 1 mM dithiothreitol at 4°C. Membranes were then hybridized 
with 32P-STMV RNA for 1 h at room temperature in re-naturing buffer containing 2 
mg/ml of yeast tRNA. The membrane was washed twice with re-naturing buffer at room 
temperature to remove any unbound RNA, followed by autoradiography. For Far-
Northwestern analysis 14, after performing Northwestern analysis as described above, 
hybridization of the membrane was performed with a mixture containing 32P-labelled 
STMV RNA transcripts and in vitro translated STMV CP. 
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Figure 1.  Genome organization of STMV. A) Genome organization of Satellite 
tobacco mosaic virus (STMV) highlighting the 25 N-terminal amino acids (aa) of its coat 
protein ORF. The positively charged arginine (R) and lysine (K) residues are highlighted 
in red. B) Graphic representation of the disordered probability of the 159 aa residues of 
STMV CP was by DisProt analysis. The hatched region indicates a previously identified 
RNA-binding domain (see text for details). In the bottom panel, aa having a score equal 
or above 0.5 and below 0.5 are considered to be disordered and ordered, respectively. 
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C) T-DNA based agro-constructs of STMV and its CP derivatives. Characteristic 
features of agroconstructs pRP and pSTMV were described previously 9. CPKO, an 
STMV CP variant is characterized by having a 162UAG164 stop codon in the place of 
an162AUG164 start codon. CP variant CPD13aa is engineered to express CP lacking the 
N-terminal 13aa motif due to the presence of a stop codon between nt 162-164 
(162UAG164) and a start codon between nt 200-202(200AUG202). CP variant CP13aa is 
engineered to express only the N-terminal 13aa motif by having a stop codon at amino 
acid position 14 located between nt 200-202 (200UAG202). Each agroconstruct contains 
in sequential order (L to R), double Cauliflower mosaic virus (CaMV) 35S promoters 
(indicated by arrowheads), a ribozyme (R, indicated by a bent arrow) derived from 
Tobacco ring spot virus (TRSV) and a NOS terminator (T). The size in nucleotides (nt) 
of ectopically expressed RNA transcripts and the expected nature of proteins in each 
case are shown to the right. The numbers shown in parentheses are the numbers of 
non-viral RNA nucleotides left after self-cleavage by the ribozyme (R). 
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Figure 2. STMV progeny analysis. A) STMV plus (+) and minus (-) strand progeny 
RNA and CP were respectively probed by Northern and Western blot analysis. RT-PCR 
assay of wt STMV and the indicated CP variants was performed using total RNA 
isolated from leaves harvested at 4 dpi. B) Quantitative analysis of (+) and (-) progeny 
RNA of wt STMV and each CP variant was performed by scanning the autoradiographs 
using a Typhoon Phosphoimage scanner (Model 9410, GE Health Care) followed by 
ImageQ software analysis. Data was quantitated and compared internally with each 
 34 
levels of (+) and (-)-strands to that of wild type. Conditions for Northern and Western 
blots and RT-PCR analysis are as described previously 9.The positions of full length and 
truncated CP, full length and truncated STMV RNA are indicated on the left. C) Virion 
analysis. The physical morphology of negatively stained purified virions of wt STMV (left 
panel) and its CP variants (right panel) was examined by Electron microscopy 9. Bar=50 
nm. 
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Figure 3. Mutational analysis of the N-terminal 13aa motif of STMV CP. (A) 
Characteristic features of the agroconstruct of CP 13aa is shown under Fig. 1C. The N-
terminal 13aa sequence of the CP is indicated below the line diagram. In the clone 
13aa, the location of the positively charged amino acids are indicated by a + sign. In 
each variant clone the location of the engineered alanine mutation is indicated by an 
underline. The nomenclature used to designate each variant is exemplified by 13aa/XA, 
where X is characterized by an alanine (A) substitution for arginine (R, at positions 3 
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and 10) or lysine (K at positions 5, 7 and 11). (B) Progeny analysis of N-terminal 13aa 
motif variants by Northern blot and RT-PCR. Duplicate blots containing total RNA of N. 
benthamiana leaves infiltrated with the indicated samples (lanes 1 through 8) were 
hybridized with a 32P-labelled STMV probe to detect either plus (panel i) or minus (panel 
ii) sense RNA. Ribosomal RNA (rRNA) represents the loading control. Conditions used 
for Northern blot hybridization and RT-PCR is as described under the Fig. 2A legend. 
Positions of STMV and STMVD150 are indicated to the right. C) Progeny RNA 
quantification. Northern blots shown in panel B were scanned using a Phosphoimager. 
Since each mutation was engineered into the genetic background of 13aa, the absolute 
values of accumulated (+) and (-)-strand progeny RNA. for each mutant were compared 
internally to the 13aa.  
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Figure 4  Replication of full-length STMV RNA bearing mutations in the N-terminal 
13aa motif. (A) Mutations engineered into the N-terminal 13aa motif of CP. Positively 
charged amino acid residues are indicated by a + sign.  Alanine or lysine substitutions 
at designated positions are underlined. Nomenclature used to designate each mutation 
is the same as described under the Fig. 3 legend. (B-E) Progeny analysis. Total RNA 
and protein samples were isolated from leaves harvested at 4 dpi. Panels B and D 
summarize Northern blot analysis of (+) and (-)-strand accumulation for the indicated 
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variants and RT-PCR analysis. Panel C summarizes the absolute values of 
accumulated (+) and (-)-strand progeny RNA. (E) Western blot analysis of CP 
expression for indicated variants. Following co-infiltration of pRP and each variant 
agrotransformant progeny were analyzed by Northern blot hybridization, RT-PCR, 
Western blot analysis and the absolute values of accumulated (+) and (-)-strand 
progeny RNA.as described under the Figs. 2 and 3 legends.  (F) Detection of CP 3A by 
Western blot analysis using a 10-fold excess of the indicated protein samples. Positions 
of STMV and STMVD150 are indicated to the left in panels B and D. Ribosomal RNA 
(rRNA) represents loading controls for Northern blots. Position of monomeric (1x) and 
dimeric (2x) forms of STMV CP is indicated to the right in panel E. Accumulation of (+) 
and (-)-strand progeny was quantitated as described under Fig. 2 legend. 
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Figure 5. Electron microscopy and packaging phenotypes of N-terminal variants. 
(A) Electron microscopic images of virions purified indicated samples. Bar= 20 nm. (B) 
Virion RNA analysis of indicated samples (lanes 1 through 6) by Northern blot 
hybridization. BMV RNA (lane 7) was used as a size marker. (C) RT-PCR analysis of 
virion RNA recovered from N. benthamiana plants co-infiltrated with pRP and either the 
indicated variant inocula (lanes 1 through 5) or wt STMV (lane 6). (D) Biological assay 
in N. benthamiana plants mechanically inoculated with helper virus TMV-U5 and virion 
RNA of wt and the indicated STMV variant samples. 
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Figure 6. Co-immunoprecipiation assays. (A) HV RdRp (pRP) was co-expressed with 
either wt STMV CP (wt) or its indicated variants in N. benthamiana leaves by 
agroinfiltration. (i) Expression of HV RdRp, STMV CP and its variants in total protein 
extracts was confirmed by Western blotting using anti-126kDa and anti-STMV CP 
antibodies, respectively. Total protein extracts from leaves infiltrated with the empty 
vector (mock) or CP only were used as controls. (ii) For co-immunoprecipitation, total 
protein extracts of each sample were incubated first with anti-126-kDa antibody followed 
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by complex precipitation with protein-G agarose. The resulting co-immunoprecipitated 
products were subjected to Western blotting using anti-126 kDa and anti-STMV CP 
antibodies. (B) STMV CP (CP) was expressed either independently or co-expressed 
with HV RdRp in N. benthamiana leaves by agroinfiltration. Total protein extracts were 
divided into two batches: one batch was treated with RNase (+RNase) and the other 
remained untreated (-RNase). Co-immunopreciptation with anti-126 kDa followed by 
Western blot analysis was as described above. 
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Figure 7. Northwestern and Far Northwestern blot assays. A) RNA-CP interaction 
detected by Northwestern blot analysis: Triplicate blots containing in vitro translation 
products of indicated samples were generated following 12% SD-PAGE analysis. The 
first blot (i) was subjected to Western blot analysis using anti-STMV CP antibody while 
the second (ii) and third (iii) blots were respectively subjected to hybridization with 32P-
labeled STMV (+) and (-)-strand riboprobes and visualized using autoradiography. The 
positions of monomeric (1x) and dimeric (2x) forms of STMV CP are indicated to the 
right. B). Requirement of CP to promote interaction between HV RdRp and STMV RNA 
was detected by Far Northwestern blot analysis: HV RdRp (183 kDa) or, BMV RdRp 
(109 and 94 kDa) and BMV CP (19 kDa) (negative controls) and Wt and 3A variant of 
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STMV CP (17.5 kDa) were fractionated by either 8% (panel i) or 10% SDS-PAGE 
(panels ii and iii), transferred to a nitrocellulose membrane and successively denatured 
and re-natured prior to hybridizing with32P-labeled STMV RNA probe only (ii) or 
radiolabelled probe and STMV CP (iii). Western blot shown in panel (i) represents input 
control analyzed using a mixture of antibodies raised against TMV-RdRp, BMV-RdRp, 
BMV CP and STMV CP antibodies.  
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 Figure 8. Free energy of assembly. Encapsidation free energy vs the genome length 
for wt CPs (solid black curve) and mutated CPs (dashed red curve). The blue dots 
correspond to the encapsidation free energy of STMVD150 RNA and the orange 
squares to wt STMV RNA. Energies are in units of thermal energy kBT. See the text and 
Ref 30 for further details of the model. 
 
